Crux Wealth Advisors Novartis Ag Transaction History
Crux Wealth Advisors
- $180 Billion
- Q4 2024
A detailed history of Crux Wealth Advisors transactions in Novartis Ag stock. As of the latest transaction made, Crux Wealth Advisors holds 4,132 shares of NVS stock, worth $452,288. This represents 0.22% of its overall portfolio holdings.
Number of Shares
4,132Holding current value
$452,288% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,488Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$896 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$752 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...